Projects per year
Personal profile
Chinese Name
李芳菲
Biography
Dr. Li Fangfei graduated from Ocean University of China with a bachelor's degree in Chemistry in 2007. Following two years of master education in Ocean University, she started her PhD study in Australia under China Scholarship Council (CSC) scholarship in 2009. Dr. Li obtained her PhD degree in Chemistry from University of New South Wales in Australia in 2013. After postdoctoral training at Institute of Microbiology, Chinese Academy of Science in Beijing, she joined school of Chinese Medicine at Hong Kong Baptist University as a postdoctoral fellow in 2015, and then served as a research assistant professor since 2016. In 2021, Dr. Li was appointed as a tenure-track assistant professor.
Research Interests
novel anti-cancer therapies and targeted drug delivery.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, UNSW Sydney
Award Date: 31 Dec 2013
Fingerprint
Dive into the research topics where Fangfei LI is active. Topic labels come from the works of this scholar.
- 1 Similar Scholars
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Equipment Matching Fund - High-performance Slide Scanner
LIU, J., LI, F., YU, Y., XU, J., FU, X., WONG, H. L. X., KWAN, H. Y. & CHONG, W. P.
26/03/24 → 25/03/26
Project: Research project
-
-
Osteosarcoma-specific delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in a patient-derived xenograft model
1/01/19 → 31/12/22
Project: Research project
-
Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release
Ma, Y., Xie, D., Chen, Z., Shen, X., Wu, X., Ding, F., Ding, S., Pan, Y., Li, F., Lu, A. & Zhang, G., 1 Jul 2024, In: Journal of Translational Medicine. 22, 1, 13 p., 604.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Aloperine Suppresses Cancer Progression by Interacting with VPS4A to Inhibit Autophagosome-lysosome Fusion in NSCLC
Guo, W., Zhou, H., Wang, J., Lu, J., Dong, Y., Kang, Z., Qiu, X., Ouyang, X., Chen, Q., Li, J., Cheng, X., Du, K., Li, M., Lin, Z., Jin, M., Zhang, L., Sarapultsev, A., Shi, K., Li, F., Zhang, G., & 8 others, 21 Aug 2024, In: Advanced Science. 11, 31, 21 p., 2308307.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Discovery of a core inflammatory gene network associated with poor prognosis and characterized immune infiltration pattern in pancreatic ductal adenocarcinoma
Yang, L., Chen, Z., Sheng, Y., Chowdhury, D., Yip, H. F., Qiao, S., Sun, M., Lu, A. & Li, F., 15 Jan 2024, In: Cancer Research. 84, 2 (Supplement), C042.Research output: Contribution to journal › Conference article › peer-review
-
Inflammatory gene-based subtyping of osteosarcoma patients reveals the association of inflammation in tumor microenvironment with better survival
Yang, L., Sheng, Y., Qiao, S., Hu, D., Chowdhury, D., Yip, H. F., Chen, Z., He, Y., Lu, A. & Li, F., 15 Mar 2024, In: Cancer Research. 84, 6 (Supplement), 5459.Research output: Contribution to journal › Conference article › peer-review
-
Intracellular sclerostin plays a vital role in tumor progression and metastasis in triple-negative breast cancer
Sun, M., Qiao, S., Luo, H., Yang, X., Yang, L., Zhang, H., Chen, Z., Wang, L., Tao, X., Yu, Y., Ma, Y., Yuan, F., Ma, D., Chen, Q., Lu, A., Zhang, B. T., Zhang, G. & Li, F., 1 Feb 2024, In: Cancer Research. 84, 3, Supplement 1, B044.Research output: Contribution to journal › Conference article › peer-review
Prizes
-
Second Prize in Life Sciences
LI, Fangfei (Recipient) & LIU, Jin (Recipient), 23 May 2017
Prize: Award
File -
The 8th Hong Kong University Student Innovation and Entrepreneurship Competition
LI, Fangfei (Recipient), 2022
Prize: Award
File
Activities
-
Frontiers in Oncology (Journal)
Fangfei LI (Associate editor)
2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Experimental Cell Research (Journal)
Fangfei LI (Reviewer)
18 Jun 2024Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
External Reviewer of University of Macau Multi-year Research Grant ( General Research Grant )
Fangfei LI (Advisor)
16 Apr 2024 → 20 Apr 2024Activity: Consultancy
-
Frontiers in Immunology (Journal)
Fangfei LI (Associate editor)
2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
International Journal of Molecular Sciences (Journal)
Fangfei LI (Reviewer)
19 Apr 2024Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)